Thus, the alterations to the AR cistrome observed by Pomerantz and colleagues in mCRPC, such as those associated with prostate developmental programs, may be more relevant for prostate cancer metastasis, rather than the development of castration-resistance per se. The gene discussed is AR; the disease is prostate carcinoma.